Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Dow
Johnson and Johnson
Federal Trade Commission
Fish and Richardson
Cerilliant
Harvard Business School
Cantor Fitzgerald
Teva
Farmers Insurance

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090896

« Back to Dashboard

NDA 090896 describes CHLOROTHIAZIDE SODIUM, which is a drug marketed by Fresenius Kabi Usa, Luitpold, Mylan Institutional, Sagent Pharms, and Sun Pharma Global, and is included in five NDAs. It is available from four suppliers. Additional details are available on the CHLOROTHIAZIDE SODIUM profile page.

The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.

Summary for 090896

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 090896

Ingredient-typeThiazides
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 090896

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 090896 ANDA Fresenius Kabi USA, LLC 63323-658 63323-658-20 1 VIAL in 1 BOX (63323-658-20) > 18 mL in 1 VIAL
CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 090896 ANDA Fresenius Kabi USA, LLC 63323-658 63323-658-27 1 VIAL in 1 BOX (63323-658-27) > 18 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Oct 16, 2009TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Mallinckrodt
Johnson and Johnson
Fuji
Accenture
Cipla
Queensland Health
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot